Daratumumab, Bortezomib, and Dexamethasone for Previously Treated Multiple Myeloma
Year: 2023
Type: letter
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.22.02665
Institution: The Second Nanning People's Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4327908868
